EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences

EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Médéa Locquet, Charlotte Beaudart, Jean Pétermans, Jean‐Yves Reginster, Olivier Bruyère
Format:	Carta
Jezik:	angleščina
Izdano:	2019
Online dostop:	https://doi.org/10.1016/j.jamda.2018.11.027 http://www.jamda.com/article/S1525861018306765/pdf
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Comparison of the performance of five screening methods for sarcopenia
od: Locquet, Médéa, et al.
Izdano: (2017)

Comparison of the performance of five screening methods for sarcopenia
od: Médéa Locquet, et al.
Izdano: (2017)

Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitions
od: Beaudart, Charlotte, et al.
Izdano: (2017)

Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitions
od: Charlotte Beaudart, et al.
Izdano: (2017)

Sarcopenia for predicting falls and hospitalization in community-dwelling older adults: EWGSOP versus EWGSOP2
od: Yang, Ming, et al.
Izdano: (2019)

Sarcopenia for predicting falls and hospitalization in community-dwelling older adults: EWGSOP versus EWGSOP2
od: Ming Yang, et al.
Izdano: (2019)

Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients
od: Jens Reiss, et al.
Izdano: (2019)

The health economics burden of sarcopenia: a systematic review
od: Olivier Bruyère, et al.
Izdano: (2018)

Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review
od: Lara Vilar Fernandes, et al.
Izdano: (2021)

Relationship between smoking and the incidence of sarcopenia: The SarcoPhAge cohort
od: Médéa Locquet, et al.
Izdano: (2021)

Evaluation of the Responsiveness of the SarQoL(®) Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia
od: Geerinck, Anton, et al.
Izdano: (2018)

Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia
od: Charlotte Beaudart, et al.
Izdano: (2017)

Self-Medication Practice Among Older Adults: Prevalence and Associated Factors
od: Locquet, Medea, et al.
Izdano: (2020)

Malnutrition as a Strong Predictor of the Onset of Sarcopenia
od: Beaudart, Charlotte, et al.
Izdano: (2019)

Malnutrition as a Strong Predictor of the Onset of Sarcopenia
od: Charlotte Beaudart, et al.
Izdano: (2019)

PREVALENCE AGREEMENT AND PROGNOSTIC VALUE OF EWGSOP AND FNIH SARCOPENIA DEFINITION: THE GLISTEN STUDY
od: Volpato, S, et al.
Izdano: (2018)

Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)
od: Cruz-Jentoft, Alfonso J., et al.
Izdano: (2014)

Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)
od: Alfonso J. Cruz‐Jentoft, et al.
Izdano: (2014)

Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program
od: Shafiee, Gita, et al.
Izdano: (2020)

Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program
od: Gita Shafiee, et al.
Izdano: (2020)

SARCOPENIA ACCORDING TO BRAZILIAN AND EWGSOP 2 CUTOFFS: DATA FROM SARCOS
od: Menezes, Julia M, et al.
Izdano: (2019)

SARCOPENIA ACCORDING TO BRAZILIAN AND EWGSOP 2 CUTOFFS: DATA FROM SARCOS
od: Julia Miranda Menezes, et al.
Izdano: (2019)

Impact of using the updated EWGSOP2 definition in diagnosing sarcopenia: A clinical perspective
od: Jeanine M. Van Ancum, et al.
Izdano: (2020)

DETERMINING THE PREVALENCE OF SARCOPENIA IN AN INPATIENT GERIATRIC POPULATION USING EWGSOP2 OR FNIH DEFINITIONS
od: Scholl, Matthew M, et al.
Izdano: (2019)

Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition
od: Roswitha Dietzel, et al.
Izdano: (2022)

Impact of Malnutrition Status on Muscle Parameter Changes over a 5-Year Follow-Up of Community-Dwelling Older Adults from the SarcoPhAge Cohort
od: Lengelé, Laetitia, et al.
Izdano: (2021)

Sarcopenia and health‐related quality of life: A systematic review and meta‐analysis
od: Charlotte Beaudart, et al.
Izdano: (2023)

Can EWGSOP2 and SDOC Definitions of Sarcopenia Identify Functional Muscle Quality?
od: Patrícia Parreira Batista, et al.
Izdano: (2024)

The Predictive Value of the EWGSOP Definition of Sarcopenia: Results From the InCHIANTI Study
od: Luca Bianchi, et al.
Izdano: (2015)

Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria
od: Remelli, Francesca, et al.
Izdano: (2021)

Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People
od: Costanzo, Luisa, et al.
Izdano: (2020)

Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People
od: Luisa Di Costanzo, et al.
Izdano: (2020)

European Working Group on Sarcopenia in Older People 2010 (EWGSOP1) and 2019 (EWGSOP2) criteria or slowness: which is the best predictor of mortality risk in older adults?
od: Spexoto, Maria Claudia Bernardes, et al.
Izdano: (2022)

European Working Group on Sarcopenia in Older People 2010 (EWGSOP1) and 2019 (EWGSOP2) criteria or slowness: which is the best predictor of mortality risk in older adults?
od: Maria Cláudia Bernardes Spexoto, et al.
Izdano: (2022)

Frailty but not sarcopenia nor malnutrition increases the risk of developing COVID-19 in older community-dwelling adults
od: Lengelé, Laetitia, et al.
Izdano: (2021)

Relationship between the changes over time of bone mass and muscle health in children and adults: a systematic review and meta-analysis
od: Locquet, Médéa, et al.
Izdano: (2019)

Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL(®) questionnaire
od: Geerinck, Anton, et al.
Izdano: (2021)

Prevalence and Clinical Correlates of Sarcopenia in Community-Dwelling Older People: Application of the EWGSOP Definition and Diagnostic Algorithm
od: Volpato, Stefano, et al.
Izdano: (2014)

Sarcopenia in hospitalized geriatric patients: insights into prevalence and associated parameters using new EWGSOP2 guidelines
od: Bertschi, Dominic, et al.
Izdano: (2020)

Prevalence and Clinical Correlates of Sarcopenia in Community-Dwelling Older People: Application of the EWGSOP Definition and Diagnostic Algorithm
od: Stefano Volpato, et al.
Izdano: (2013)